Hemodialysis is a medical treatment that filters waste products, excess fluid, and toxins from your blood when your kidneys can no longer do the job on their own. A machine draws blood out of your body through tubing, passes it across a specialized membrane inside a device called a dialyzer, and returns the cleaned blood. The process mimics some of what healthy kidneys do naturally, though imperfectly, and it keeps millions of people with kidney failure alive worldwide. The mechanics of how it accomplishes this, and the practical realities of living with the treatment, are worth understanding whether you or someone you know is facing it.
How Blood Gets Cleaned Outside the Body
Your kidneys filter roughly 180 liters of fluid a day, but they do it continuously and with extraordinary precision. Hemodialysis compresses that work into a few hours, typically three sessions per week lasting about four hours each. The core principle is surprisingly simple: blood flows on one side of a thin membrane, and a specially mixed cleaning fluid called dialysate flows on the other side. Waste molecules like urea and creatinine drift across the membrane from the blood (where concentrations are high) into the dialysate (where concentrations are low). This movement, driven by the concentration difference between the two fluids, is called diffusion.
The direction the dialysate flows matters. In most machines, blood and dialysate travel in opposite directions, a setup called counter-current flow. Running the fluids this way maintains a concentration difference along the entire length of the filter, which keeps waste removal efficient from start to finish. When the fluids run in the same direction instead, clearance of small waste molecules drops by roughly 14 percent, and clearance of medium-sized molecules drops even more.1PubMed. Diffusive clearance of small and middle-sized molecules in combined dialyzer flow configurations In critically ill patients on continuous dialysis, counter-current flow has been associated with about a 20 percent improvement in the removal of creatinine and urea compared with same-direction flow.2PubMed. Con-Current versus Counter-Current Dialysate Flow during CVVHD. A Comparative Study for Creatinine and Urea Removal
Diffusion handles small waste molecules well, but the body also accumulates excess water between sessions, and that needs to come out too. The machine applies a pressure difference across the membrane to push water from the blood side to the dialysate side, a process called ultrafiltration. Modern machines have automatic controls that regulate how much fluid is removed per hour, which is critical because pulling water out too fast can cause blood pressure to crash.
The Dialyzer and the Dialysate
The dialyzer, sometimes called the artificial kidney, is a plastic cartridge roughly the size of a large water bottle. Inside it are thousands of hollow fibers, each thinner than a human hair. Blood flows through the insides of these tiny tubes while dialysate flows around the outside. The combined surface area of all those fibers gives the dialyzer enough membrane to filter blood effectively in a compact space.
Early dialyzers used cellulose-based membranes, which had a uniform structure but tended to trigger inflammatory reactions. Modern dialyzers almost exclusively use synthetic polymer membranes made from materials like polysulfone or polyethersulfone. These synthetic membranes have an asymmetric design: a dense inner layer that contacts the blood and controls which molecules pass through, and a spongy outer layer that provides structural support. By eliminating the hydroxyl groups found on cellulose surfaces, synthetic polymers reduce the immune activation that older membranes provoked.3PubMed Central. Biocompatibility in hemodialysis: artificial membrane and human blood interactions
The dialysate is not just water. It is a precisely mixed solution containing electrolytes like sodium, potassium, calcium, and magnesium, along with a buffer, usually bicarbonate, to correct the acid buildup that failing kidneys cannot handle. One of dialysis’s major roles is acid buffering through this base supplementation, and the bicarbonate concentration in the dialysate should ideally be adjusted for each patient to reach a target level in the blood between sessions.4Nephrology Dialysis Transplantation. Optimal composition of the dialysate, with emphasis on its influence on blood pressure Getting the dialysate recipe wrong can cause problems ranging from muscle cramps to dangerous heart rhythms, so the electrolyte composition remains an active area of clinical research.5PubMed Central. Dialysate Composition for Hemodialysis: Changes and Changing Risk
Getting Blood In and Out
Before hemodialysis can happen, there has to be a reliable way to move large volumes of blood from your body into the machine and back again. This is called vascular access, and the type you have makes a bigger difference to your health outcomes than most people realize. There are three main options.
- Arteriovenous fistula (AVF): A surgeon connects an artery directly to a vein, usually in your forearm. Over several weeks, the vein enlarges and strengthens enough to handle repeated needle sticks. Fistulas are considered the gold standard because they last the longest and carry the lowest risk of infection and death.
- Arteriovenous graft (AVG): When a direct fistula is not feasible, a synthetic tube bridges the artery and vein. Grafts can be used sooner after surgery but tend to clot and fail more often over time.
- Central venous catheter: A flexible tube inserted into a large vein in the neck, chest, or groin. Catheters can be used immediately, which makes them common in emergencies, but they carry the highest risk of serious complications.
The differences in outcomes across these access types are substantial. A large meta-analysis found that people using catheters had roughly 53 percent higher all-cause mortality and more than double the risk of fatal infections compared with those using fistulas. Grafts fell in between, with about 18 percent higher mortality than fistulas.6PubMed Central. Associations between hemodialysis access type and clinical outcomes: a systematic review Fistulas do have a catch, though: they fail to mature and become usable more often than grafts do initially. But once working, fistulas maintain better long-term patency at one, two, and five years.7PubMed. Impact of arteriovenous fistulas versus arteriovenous grafts on vascular access performance in haemodialysis patients: A systematic review and meta-analysis The survival advantage of fistulas over grafts has been shown to be particularly strong in men and in patients with diabetes.8American Journal of Nephrology. Comparison of Outcomes with Arteriovenous Fistula and Arteriovenous Graft for Vascular Access in Hemodialysis: A Prospective Cohort Study
Keeping Blood From Clotting in the Circuit
When blood travels through plastic tubing and across a synthetic membrane, it wants to clot. Without anticoagulation, the dialyzer would clog within minutes, ending the session early and wasting blood trapped in the circuit. The two main approaches are systemic heparin and regional citrate.
Heparin is the traditional choice: a blood-thinning drug given through your IV line that prevents clotting throughout your entire body during the session. It works well but carries a bleeding risk, which matters especially in hospitalized patients who may have had recent surgery or have other reasons they might bleed. Regional citrate anticoagulation takes a different approach. Citrate is infused into the blood just before it enters the dialyzer, where it binds calcium and prevents clotting locally within the circuit. After the blood passes through the filter, calcium is replaced before the blood returns to your body, so your normal clotting ability stays intact.9JAMA. Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality Among Critically Ill Patients With Acute Kidney Injury In both approaches, the target is a specific range of clotting markers: for heparin, keeping the activated partial thromboplastin time between roughly 45 and 65 seconds; for citrate, keeping the ionized calcium level after the filter very low, around 0.25 to 0.35 mmol/L.10Kidney International. Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients
What Can Go Wrong During a Session
The most common acute complication is a sudden drop in blood pressure, called intradialytic hypotension. It is defined as a rapid fall in systolic blood pressure of 20 mmHg or more that causes symptoms and requires intervention, such as slowing down fluid removal or giving saline. This happens because the machine is pulling fluid out of the bloodstream faster than the body can refill it from surrounding tissues. Patient factors like age, heart disease, and medications contribute, as do dialysis-prescription factors like the total volume being removed and how quickly.11PubMed Central. Prevention of Intradialytic Hypotension in Hemodialysis Patients: Current Challenges and Future Prospects Minimizing weight gain between sessions, so there is less fluid to remove each time, is one of the most practical ways to reduce the risk.
A rarer but more dramatic problem is dialysis disequilibrium syndrome. When urea is cleared rapidly from the blood, a temporary gap develops between urea levels in the blood and urea levels in the brain. Because the brain’s transporter proteins for urea are relatively sparse, urea exits brain cells slowly while water rushes in, causing the brain to swell. Symptoms range from headache and nausea to seizures in severe cases.12Nephrology Dialysis Transplantation. Molecular basis for the dialysis disequilibrium syndrome: altered aquaporin and urea transporter expression in the brain Disequilibrium is most likely to happen during the first few dialysis sessions, particularly if the initial urea levels are very high, which is why new patients are often started with shorter, gentler treatments.
Beyond acute events, hemodialysis itself triggers a low-grade immune response. Contact between blood and the artificial membrane activates platelets and stirs up oxidative stress, contributing to a state of chronic subclinical inflammation that has been linked to increased cardiovascular risk over time.13PubMed Central. Immune System Dysfunction and Inflammation in Hemodialysis Patients: Two Sides of the Same Coin
Managing Fluid Removal
Getting the right amount of fluid off during each session is one of the trickiest parts of hemodialysis. The goal is to bring you down to your “dry weight,” the weight at which you have a normal fluid balance with no excess swelling or congestion. But dry weight is not a fixed number; it shifts as your nutrition, muscle mass, and overall health change. There is no single measurement that pins it down perfectly. Clinicians rely on a combination of signs: blood pressure before and during the session, the presence or absence of swelling in your legs, shortness of breath, muscle cramps, lightheadedness, and how fatigued you feel afterward.14PubMed Central. Volume Balance and Intradialytic Ultrafiltration Rate in the Hemodialysis Patient
Newer machines can monitor changes in blood volume in real time and adjust the fluid-removal rate automatically. Even with this technology, the evidence makes clear that pushing fluid removal too aggressively backfires. Rapid ultrafiltration is associated with drops in blood pressure, organ damage from reduced blood flow, and worse long-term outcomes.15PubMed Central. Blood volume-monitored regulation of ultrafiltration to decrease the dry weight in fluid-overloaded hemodialysis patients: a randomized controlled trial This is why dietitians emphasize limiting salt and fluid intake between sessions: the less weight you gain between treatments, the less the machine has to pull off, and the smoother the session tends to go.
Measuring Whether Dialysis Is Working
Dialysis adequacy is tracked primarily by measuring how well the treatment clears urea from the blood. The most common metric compares the urea concentration in blood samples drawn before and after a session. A simple version of this is the urea reduction ratio, while a more detailed calculation called Kt/V factors in the volume of water in your body, the treatment time, and the dialyzer’s clearance rate. Most guidelines recommend a minimum Kt/V of 1.2 per session for standard three-times-weekly hemodialysis.16PubMed Central. Nephrology Dialysis Adequacy: A Cross-Sectional Study to Assess the Reliability of the Online Clearance Monitor to Measure Dialysis Dose
Some modern machines estimate Kt/V in real time using an online clearance monitor, which measures how well the dialyzer is clearing waste without requiring a blood draw. While these monitors correlate well with blood-based measurements, their precision for replacing blood sampling entirely is still debated. Beyond urea, though, many clinicians recognize that small-molecule clearance alone does not capture the full picture of whether someone is “adequately” dialyzed. Larger toxins, fluid balance, nutritional status, and how the patient actually feels all matter, and none of those are captured by Kt/V.17PubMed Central. Assessment of dialysis adequacy: beyond urea kinetic measurements
In-Center, at Home, and Different Schedules
The standard setup for hemodialysis is three sessions a week at a dialysis center, each lasting about four hours. You sit in a recliner, the nurses connect you to the machine, and you wait. Many patients read, watch TV, sleep, or work on a laptop during sessions. But center-based dialysis dominates your weekly schedule, and it is one of the biggest quality-of-life complaints patients have.
Home hemodialysis is an alternative that allows patients to dialyze in their own home, often on a more flexible schedule. A small crossover trial found that home hemodialysis with longer sessions reduced 24-hour blood pressure and improved uremic symptoms compared with standard in-center treatment, though it increased the perceived burden of managing the treatment at home.18PubMed Central. Home versus in-centre haemodialysis for end-stage kidney disease Comparing survival between home and in-center dialysis is complicated by the fact that home dialysis patients tend to be younger, healthier, and more motivated, and they frequently perform more total dialysis hours per week than center patients do. Some observational studies suggest a survival advantage for intensive home dialysis, likely related to better fluid balance and waste removal, but the existing evidence is muddied by these selection biases.19PubMed Central. Survival Comparisons of Home Dialysis Versus In-Center Hemodialysis: A Narrative Review
Hemodialysis Versus Peritoneal Dialysis
Hemodialysis is not the only form of dialysis. Peritoneal dialysis uses the lining of your abdomen as the filter membrane instead of an external machine. A catheter in the belly allows dialysate to be infused and drained, and exchanges can happen overnight while you sleep or throughout the day. The choice between the two depends on medical factors, lifestyle, and personal preference.
A large propensity-matched study of new dialysis patients found that peritoneal dialysis was associated with slightly better early survival overall, with cumulative survival of about 86 percent versus 81 percent at one year. By three to four years, however, the survival curves essentially converged. Peritoneal dialysis showed a clearer survival advantage in patients under 65 and in those without diabetes or cardiovascular disease. In patients who did have diabetes or heart disease, hemodialysis tended to perform slightly better over time.20PubMed Central. Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients Neither modality is universally superior; the best choice depends on the individual.
Long-Term Consequences of Years on Dialysis
Even with adequate treatment, hemodialysis cannot fully replace everything healthy kidneys do. One of the most consequential long-term effects is vascular calcification, where calcium and phosphate deposits build up in blood vessel walls and heart valves. Failed kidneys struggle to maintain the balance of phosphorus and calcium in the blood, and the resulting mineral dysregulation, combined with chronic inflammation and disruptions to bone metabolism, drives calcification of arteries. An inverse relationship has been documented between vascular calcification and bone density in kidney failure patients, suggesting that some of the calcium leaving weakened bones ends up in blood vessel walls instead.21Blood Purification. Why Do Patients Develop a Heart of Stone and Bone of China?
Fatigue is another hallmark of long-term dialysis. It is consistently ranked as one of the most disabling symptoms patients experience, and it is associated with reduced quality of life, impaired daily functioning, and higher mortality. Post-dialysis fatigue, the severe exhaustion that follows many sessions, can take hours to resolve and effectively shortens the “good” time patients have between treatments.22PubMed Central. Interventions for fatigue in people with chronic kidney disease requiring dialysis Managing fatigue remains one of the most underserved areas in dialysis care, partly because the causes are tangled up with anemia, inflammation, sleep disruption, and depression.
How the Technology Got Here
The earliest experiments with artificial blood filtration go back to the beginning of the 20th century, using animal membranes and a leech-derived anticoagulant called hirudin. A few attempts in humans were made in the 1920s, but progress remained slow until cellophane membranes and heparin anticoagulation came into use in the late 1930s and 1940s.23PubMed. History of hemodialyzers’ designs Willem Kolff, a Dutch physician, is widely credited as the father of the artificial kidney. His rotating drum dialyzer, built during World War II, evolved into the machines that made long-term dialysis a reality for patients with permanent kidney failure.24PubMed Central. Dr. Willem Kolff: The Father of the Artificial Kidney
The 1950s and 1960s saw an explosion of new dialyzer designs, culminating in the capillary (hollow-fiber) dialyzers that remain the standard today. Dialysate delivery also underwent a transformation during this period, moving from tanks of recirculated solution to single-pass systems that use fresh dialysate and discard it after one trip through the machine. By the end of the 20th century, systems capable of producing ultrapure dialysate and automatically preparing the machine for the next session had been developed, making home hemodialysis more practical.23PubMed. History of hemodialyzers’ designs
Wearable and Implantable Kidneys on the Horizon
For all its life-saving capability, conventional hemodialysis ties patients to a machine for hours several times a week. The ultimate goal for researchers is a device that works continuously, the way real kidneys do. Two broad approaches are in development: wearable artificial kidneys and implantable bioartificial kidneys.
Wearable devices aim to miniaturize the dialysis circuit into something a patient could carry on their body. Automated wearable artificial kidneys have undergone small human trials, though none has reached widespread clinical use yet.25PubMed. Innovations in Wearable and Implantable Artificial Kidneys One challenge is replacing the tubular function of real kidneys, which reabsorb useful substances from filtered fluid and perform metabolic tasks that no synthetic membrane can mimic. To address this, researchers have developed bioartificial kidney devices that combine a miniature hemofilter with living kidney tubule cells grown on hollow-fiber membranes.26PubMed. Research into the development of a wearable bioartificial kidney with a continuous hemofilter and a bioartificial tubule device using tubular epithelial cells One such system, the Bioartificial Renal Epithelial Cell System, has been tested in large animals using peritoneal dialysis fluid to sustain the cells and deliver therapy. In those experiments, the cell-based devices maintained viability for up to a week and showed measurable effects on immune function compared with devices without cells.27PubMed. Development of a wearable bioartificial kidney using the Bioartificial Renal Epithelial Cell System (BRECS)
An implantable version, envisioned as a biohybrid combining silicon nanofilters with living renal cells, is still in preclinical stages. The engineering challenges are formidable: the device needs to filter blood continuously using only the body’s own blood pressure, avoid triggering immune rejection, and last for years without maintenance. None of these problems has been fully solved, but the pace of materials science and cell biology research makes the concept less far-fetched than it would have sounded a generation ago. For the roughly three million people worldwide currently on hemodialysis, even a partially successful wearable device could transform daily life in ways that incremental improvements to existing machines cannot.